PRICE T ROWE ASSOCIATES INC /MD/
Position in TRDA — Entrada Therapeutics, Inc.
CIK 80255
BALTIMORE, MD
Position in TRDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,991,445
-$2,647,217 QoQ
Shares Held
542,316
+3.1% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#14
of 128 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in TRDA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,963,376 across 304 Biotechnology names. TRDA ranks #134 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in TRDA
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,991,445 | 542,316 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $6,638,662 | 526,043 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,365,907 | 327,423 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,091,050 | 360,526 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,253,451 | 2,567,478 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,740,373 | 2,736,767 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $50,193,301 | 2,903,025 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,732,159 | 3,049,572 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $44,666,025 | 3,134,458 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,015,068 | 2,753,357 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $45,415,964 | 3,009,673 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $47,400,583 | 3,000,037 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $44,485,982 | 2,938,308 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $43,266,013 | 2,983,863 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $40,754,377 | 3,014,377 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $46,839,508 | 2,972,050 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $29,688,725 | 2,437,498 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,425,364 | 2,494,714 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $34,593,305 | 2,020,637 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||